<circle stroke="#1e77f9" class="srdi68r9" cx="25" cy="25" r="20" fill="none" stroke-width="5">

Sanofi says tolebrutinib did not meet primary endpoint in PERSEUS phase 3 study

PremiumThe Fly

3d ago

Sanofi: Buy Rating Maintained Amid Attractive Valuation and Long-Term Growth Potential Despite Pipeline Setbacks

PremiumRatings

3d ago

Sanofi says Qfitlia, Cablivi approved in China for rare hematologic diseases

PremiumThe Fly

7d ago

Sanofi price target lowered to EUR 100 from EUR 102 at HSBC

PremiumThe Fly

8d ago

PremiumThe FlyGuggenheim downgrades Sanofi on lack of near-term pipeline catalysts

9d ago

Sanofi downgraded to Neutral from Buy at Guggenheim

The Fly

Sanofi downgraded to Neutral from Buy at Guggenheim

9d ago

Sanofi downgraded to Neutral from Overweight at JPMorgan

The Fly

Sanofi downgraded to Neutral from Overweight at JPMorgan

10d ago

Trump Weekly: President approves U.S. manufacturing of ‘tiny cars’

PremiumThe Fly

13d ago

PremiumThe Fly

FDA shift in drug study requirements sends trial runners lower

14d ago

FDA to reduce number of trials required for drug approvals, STAT reports

PremiumThe Fly

14d ago

FDA to reduce number of trials required for drug approvals, STAT reports

PremiumThe Fly

14d ago

PremiumThe FlyTop drug regulator Richard Pazdur preparing to exit FDA, STAT News reports

16d ago

Vaccine committee considers changes to childhood schedule, NY Times reports

The Fly

Vaccine committee considers changes to childhood schedule, NY Times reports

16d ago

Midday Fly By: Nvidia invests in Synopsys, U.S. strikes pharma deal with UK

Prasad email a headwind for vaccine manufacturers, says BofA

The Fly

Midday Fly By: Nvidia invests in Synopsys, U.S. strikes pharma deal with UK

17d ago

PremiumThe Fly

17d ago

GSK

PFE

PremiumThe Fly

Trump Trade: U.S. confirms agreement with U.K. on pharmaceutical pricing

17d ago

US government confirms agreement in principle with UK on pharmaceutical pricing

PremiumThe Fly

17d ago

Sanofi price target lowered to EUR 102 from EUR 115 at BofA

PremiumThe Fly

17d ago

PremiumThe FlyUS, UK expected to agree on zero-tariffs pharmaecuticals deal, UK Times says

17d ago

Sanofi’s Undervalued Stock and Growth Prospects Drive Buy Rating Despite Near-Term Challenges

Ratings

Sanofi’s Undervalued Stock and Growth Prospects Drive Buy Rating Despite Near-Term Challenges

17d ago

Sanofi’s Parisian HQ raided in French tax fraud probe, Le Monde reports

The Fly

Sanofi’s Parisian HQ raided in French tax fraud probe, Le Monde reports

23d ago